Email Contact Phone Company Visit Website

Chicago Head Office

311 South Wacker Drive, Suite 980


0049 69 61009-104


Christophe Rilinger
[email protected]
Back to all RTS Realtime Systems AG announcements

RTS expands its business in Taiwan

Frankfurt/Sydney May 2nd, 2006

RTS Realtime Systems Group, one of the leading global Independent Software Vendors providing professional trading software to the financial community, is to offer connectivity to the Taiwan Futures Exchange (TAIFEX) and to the Taiwan Stock Exchange Corporation (TSEC).

TAIFEX currently offers futures and options on major Taiwan stock indices, government bond futures, equity options and 30-day CP interest rate futures. Within the last years it became one of the top ranked world futures exchanges.

After receiving the No Action Letter from the Commodity Futures Trading Commission (CFTC), persons and entities in the US can trade until now 4 approved contracts: TX, MTX, TE and TF – a further step for US investors to tap into the Asian markets.

Using the RTD trading platform, futures traders will benefit from a set of outstanding functionality: the new functionality in RTS’ Vertical Dartboard gives futures traders the ability to execute orders be they in extremely volatile or normal market conditions without compromising the accuracy and precision of price selection. Option traders will take advantage of RTD’s premium option functionality with integrated vola and risk management as well as a state-of-the-art Quote Machine®.

John Dempsey, Business Development Manager at RTS, comments: “There is an exponential growth in the Taiwanese market, especially in the Index Options arena. The relaxation of barriers, in particular the introduction of omnibus accounts and the permission to conduct trading for non-hedging purposes, has sparked a strong interest from our customers to participate in the Taiwanese marketplace.”

“We continue to expand our range of exchange interfaces and also to further strengthen our commitment to the Asia-Pacific region”, adds Henk Huitema, MD for Asia-Pacific at RTS in Sydney.